IGF2 and early-onset autosomal dominant Alzheimer disease: Studies on Alzheimer’s disease (AD) show conflicting results; serum IGF-II has been reported to be reduced [12], unchanged [29], or increased [30] in AD, whereas IGF-II in the cerebrospinal fluid (CSF) has mostly been observed to be increased [12,29].